Invention Grant
- Patent Title: Oxadiazoanthracene compounds for the treatment of diabetes
- Patent Title (中): 用于治疗糖尿病的恶二唑类化合物
-
Application No.: US14556837Application Date: 2014-12-01
-
Publication No.: US09120813B2Publication Date: 2015-09-01
- Inventor: Adnan M. M. Mjalli , Dharma Rao Polisetti , Thomas Scott Yokum , Santhosh Kalpathy , Mustafa Guzel , Christopher Behme , Stephen Thomas Davis
- Applicant: TransTech Pharma, LLC
- Applicant Address: US NC High Point
- Assignee: vTv Therapeutics LLC
- Current Assignee: vTv Therapeutics LLC
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Main IPC: C07D498/04
- IPC: C07D498/04 ; C07D498/14
Abstract:
The present invention provides methods of use of oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof, wherein A, B, C, R, R1, R2, R3, R4 and R5 are as herein described, and wherein said methods of use include uses for the treatment of disorders and diseases, such as diabetes.
Public/Granted literature
- US20150087640A1 Oxadiazoanthracene Compounds for the Treatment of Diabetes Public/Granted day:2015-03-26
Information query
